C12N2760/20111 - CPC Classification Index

ClassID:

111080 ⎘

C12N2760/20111 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Rhabdoviridae Lyssavirus, e.g. rabies virus

Sub-classes:

C12N2760/20121 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 8
C12N2760/20122 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 63
C12N2760/20123 » Virus like particles [VLP] 1
C12N2760/20131 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 1
C12N2760/20132 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 0
C12N2760/20133 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 5
C12N2760/20134 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 119
C12N2760/20141 » Use of virus, viral particle or viral elements as a vector 0
C12N2760/20151 » Methods of production or purification of viral material 10
C12N2760/20161 » Methods of inactivation or attenuation 9
C12N2760/20171 » Demonstrated in vivo effect 23
C12N2760/20188 » For redistribution 0

Recent Application in this class:

20200354436

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

20200354435

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

20150064768

Systems and methods for virus propagation in cell cultures for vaccine manufacture